A study of platelet aggregation, thromboxane A2 and prostacyclin in central aortic and coronary sinus blood in ischemic heart disease

Indian Heart J. 1994 Jul-Aug;46(4):149-52.

Abstract

Aortic and coronary sinus platelet aggregation, thromboxane A2 (TXA2) and prostacyclin (PG12) levels were studied in fourteen patients of stable angina (SA), six of vasopastic angina (VA) and six control subjects (C). Patients of SA were studied at rest and during incremental atrial pacing and patients with VA were studied at rest and during various stages of vasospasm. Platelet aggregation was studied with different working concentrations of ADP, epinephrine and collagen. TX A2 and PGI2 concentrations were estimated by measuring levels of their stable metabolites viz. thromboxane B2 (TXB2) and 6-keto prostaglandin F1 alpha (PGF1 alpha) respectively. Platelet aggregation was increased in SA and VA patients (p < 0.01) and further increase was seen during vasospasm (p < 0.001). However, it failed to increase on incremental atrial pacing. Similarly, TXB2 and PGF1 alpha levels were raised in SA and VA patients. While TXB2 further increased during vasospasm but not during atrial pacing. PGF1 infinity failed to rise with either. Thus platelets are in an activated state in SA and VA. This activated state is a cause and not an effect in SA and VA. An imbalance in the levels of TXA2 and PG12 could account for the vasospasm.

MeSH terms

  • Age Factors
  • Angina Pectoris / blood
  • Angina Pectoris / physiopathology*
  • Blood Platelets / physiology
  • Coronary Vasospasm / blood
  • Coronary Vasospasm / physiopathology*
  • Epoprostenol / blood*
  • Female
  • Humans
  • Male
  • Matched-Pair Analysis
  • Middle Aged
  • Platelet Aggregation*
  • Sex Factors
  • Thromboxane A2 / blood*

Substances

  • Thromboxane A2
  • Epoprostenol